Correlation Between Ningbo MedicalSystem and Yili Chuanning

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Yili Chuanning at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Yili Chuanning into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Yili Chuanning Biotechnology, you can compare the effects of market volatilities on Ningbo MedicalSystem and Yili Chuanning and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Yili Chuanning. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Yili Chuanning.

Diversification Opportunities for Ningbo MedicalSystem and Yili Chuanning

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Ningbo and Yili is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Yili Chuanning Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Yili Chuanning Biote and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Yili Chuanning. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Yili Chuanning Biote has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Yili Chuanning go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Yili Chuanning

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to generate 0.8 times more return on investment than Yili Chuanning. However, Ningbo MedicalSystem Biotechnology is 1.25 times less risky than Yili Chuanning. It trades about 0.13 of its potential returns per unit of risk. Yili Chuanning Biotechnology is currently generating about 0.09 per unit of risk. If you would invest  929.00  in Ningbo MedicalSystem Biotechnology on September 1, 2024 and sell it today you would earn a total of  232.00  from holding Ningbo MedicalSystem Biotechnology or generate 24.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Ningbo MedicalSystem Biotechno  vs.  Yili Chuanning Biotechnology

 Performance 
       Timeline  
Ningbo MedicalSystem 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.
Yili Chuanning Biote 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Yili Chuanning Biotechnology are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Yili Chuanning sustained solid returns over the last few months and may actually be approaching a breakup point.

Ningbo MedicalSystem and Yili Chuanning Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningbo MedicalSystem and Yili Chuanning

The main advantage of trading using opposite Ningbo MedicalSystem and Yili Chuanning positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Yili Chuanning can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yili Chuanning will offset losses from the drop in Yili Chuanning's long position.
The idea behind Ningbo MedicalSystem Biotechnology and Yili Chuanning Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk